Safety, Tolerability, and Pharmacokinetics of Single Rising Oral Doses of BIRB 1017 BS as a Solution in PEG 400 / 26% Ethanol Administered to Healthy Male Subjects
Clinical trial NCT02184338 · COMPLETED
Trial details
- NCT number
- NCT02184338
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-08-01
- Primary completion
- 2004-11-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.